Active substanceSodium thiosulfateSodium thiosulfate
Similar drugsTo uncover
  • Sodium thiosulfate
    solution in / in 
  • Sodium thiosulfate
    solution in / in 
    ESKOM NPK, OAO     Russia
  • Sodium thiosulfate
    solution in / in 
  • Sodium thiosulfate
    solution in / in 
    BINNOFARM, CJSC     Russia
  • Sodium thiosulfate
    solution in / in 
  • Sodium thiosulfate
    solution in / in 
    ATOLL, LLC     Russia
  • Sodium thiosulfate
    solution in / in 
    SYNTHESIS, OJSC     Russia
  • Sodium thiosulfate
    solution in / in 
    DALHIMFARM, OJSC     Russia
  • Dosage form: & nbspsolution for intravenous administration
    Composition:

    Active substance: sodium thiosulfate pentahydrate - 300 mg.

    Excipients: sodium hydrogen carbonate - 20 mg, water for injection - up to 1 ml.

    Description:

    Transparent colorless liquid.

    Pharmacotherapeutic group:Complexing agent
    ATX: & nbsp

    V.03.A.B   Antidotes

    Pharmacodynamics:

    When introduced into the body has detoxification effect. When the compounds are poisoned with arsenic, mercury, lead forms non-poisonous sulfites. When poisoned with cyanides, it forms less toxic rhodanous compounds.

    Pharmacokinetics:

    After intravenous use, it spreads into the extracellular fluid. It is excreted from the body with urine. The half-life is 0.65 hours.

    Indications:

    Poisoning by arsenic, mercury, lead, hydrocyanic acid and its salts, iodine and bromine salts.

    Contraindications:

    Hypersensitivity, children under 18 years of age (due to lack of experience of use).

    Pregnancy and lactation:During pregnancy, the drug is used solely for life indications. During lactation should refrain from breastfeeding.
    Dosing and Administration:

    The drug is administered intravenously with 5-10 ml of a solution of 300 mg / ml; when poisoning with cyanide compounds, a single dose is increased to 50 ml of a solution of 300 mg / ml.

    Side effects:

    Allergic reactions.

    Overdose:

    Cases of overdose are unknown.

    Interaction:

    Strongly forbid contact of sodium thiosulfate with nitrates, potassium permanganate.

    Special instructions:

    When cyanide poisoning is recommended, the simultaneous administration of sodium hyposulfite and sodium nitrite.

    Form release / dosage:

    Solution for intravenous administration 300 mg / ml.

    Packaging:

    For 10 ml of the drug into neutral glass ampoules.

    For 10 ampoules together with instructions for medical use and scarifier ampullum in a cardboard bundle with cardboard partitions,or 5 or 10 ampoules in a contiguous cell pack of a polyvinyl chloride film.

    When using ampoules with a notch or a fracture ring, the scarifier is not inserted.

    For 1 or 2 contour pack together with instructions for medical use in a cardboard box.

    Storage conditions:

    Store in a dark place at a temperature of no higher than 20 ° C. Keep out of the reach of children.

    Shelf life:

    5 years. Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LSR-005204/09
    Date of registration:29.06.2009
    Expiration Date:Unlimited
    The owner of the registration certificate:ESKOM NPK, OAO ESKOM NPK, OAO Russia
    Manufacturer: & nbsp
    Information update date: & nbsp25.05.2018
    Illustrated instructions
      Instructions
      Up